🔊 CEOInterviews
Start App
CEO / Investor / Company ⓘ
Topic or Keyword ⓘ
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Thibaut Mongon

Former Chief Executive Officer & Director, Kenvue

Search every verified Thibaut Mongon interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Thibaut Mongon, as CEO of Kenvue, has discussed the company’s performance and strategy following its spin-off from Johnson & Johnson in May 2023. In earnings calls and media appearances, Mongon described 2023 as a “transformational” year and highlighted the company’s financial results, including $4 billion in revenue and 7.7% organic growth in the second quarter, which he called one of the strongest quarters in the company’s history. He noted that the company maintained its guidance for the full year but tightened the range to reflect a softer start to the cold and flu season. Mongon also addressed a class action lawsuit related to the efficacy of a product, stating that the company saw no impact to the business and that the FDA had not made any determination on the matter. Mongon outlined three key priorities for 2024: reaching more consumers by focusing on 15 priority brands, freeing up resources to invest in those brands, and fostering a culture that rewards performance and impact. He acknowledged challenges in the U.S. skin health and beauty segment, particularly with the Neutrogena brand, and said that restoring its growth was a priority. Mongon also discussed the company’s employee well-being initiatives, including a global employee assistance program and a “global care day” for employees. He expressed confidence in the company’s business model and portfolio, stating that Kenvue was focused on fundamentals and building a strong foundation as an independent company.

Selected quotes

Recent appearances